Dosimetry on first clinical dark-field chest radiography
- PMID: 34314019
- DOI: 10.1002/mp.15132
Dosimetry on first clinical dark-field chest radiography
Erratum in
-
Erratum: "Dosimetry on first clinical dark-field chest radiography" Med Phys 48(10), 6152-6159.Med Phys. 2022 Jul;49(7):4933-4934. doi: 10.1002/mp.15770. Epub 2022 Jun 6. Med Phys. 2022. PMID: 35666632 No abstract available.
Abstract
Purpose: The purpose of this study was to evaluate the dose characteristic for patient examinations at the first clinical X-ray dark-field chest radiography system and to determine whether the effective patient dose is within a clinically acceptable dose range.
Methods: A clinical setup for grating-based dark-field chest radiography was constructed and commissioned, operating at a tube voltage of 70 kVp. Thermoluminescent dosimeter (TLD) measurements were conducted using an anthropomorphic phantom modeling the reference person to obtain a conversion coefficient relating dose area product (DAP) to effective patient dose at the dark-field system. For 92 patients, the DAP values for posterior-anterior measurements were collected at the dark-field system. Using the previously determined conversion coefficient, the effective dose was calculated.
Results: A reference person, modeled by an anthropomorphic phantom, receives an effective dose of 35 µSv. For the examined patients, a mean effective dose of 39 µSv was found.
Conclusions: The effective dose at the clinical dark-field radiography system, generating both attenuation and dark-field images, is within the range of reported standard dose values for chest radiography.
Keywords: TLD; X-ray dark-field; dosimetry; radiation dose.
© 2021 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.
References
REFERENCES
-
- Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11:404-406.
-
- World Health Organization. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region. 2018:2000-2016.
-
- Barreiro TJ, Perillo I. An approach to interpreting spirometry. Am Fam Physician. 2004;69:1107-1114.
-
- Kruger R, Flynn MJ, Judy PF, Cagnon CH, Seibert JA. Effective dose assessment for participants in the national lung screening trial undergoing posteroanterior chest radio-graphic examinations. Am J Roentgenol. 2013;201:142-146.
-
- Vilar-Palop J, Vilar J, Hernández-Aguado I, González-Alvarez I, Lumbreras B. Up-dated effective doses in radiology. J Radiol Prot. 2016;36:975-990.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources